Keyphrases
Australia
100%
Von Willebrand Disease
87%
Von Willebrand Factor
77%
Artemisinin
69%
Hemostasis
53%
Laboratory Testing
45%
Nuclear Medicine
38%
Virus
38%
Antioxidant Activity
36%
Radiographer
35%
Oxidative Stress
35%
Thrombosis
34%
Meta-analysis
33%
COVID-19
31%
Randomized Controlled Trial
30%
Nigeria
30%
Polyphenols
29%
Diabetes
27%
Activated Partial Thromboplastin Time (aPTT)
27%
Healthcare Professionals
26%
Beak
26%
Medical Imaging
26%
Systematic Meta-analysis
26%
Human Cytomegalovirus
25%
Computed Tomography
24%
Complementary Medicine
24%
Rice
23%
New Zealand
22%
Narrative Review
22%
Magnetic Resonance Imaging
22%
Hemostasis Testing
21%
Bee Venom
21%
Cardiovascular Disease
21%
Antioxidant
21%
Artificial Intelligence
21%
Platelets
20%
Charles Sturt University
20%
Radiography
20%
Scoping Review
20%
Image Quality
20%
Lupus Anticoagulant
20%
Phenolic Compounds
20%
Patient Safety
20%
Type 1 Diabetes Mellitus (T1DM)
20%
Structural Characterization
19%
Risk Factors
19%
Healthcare
19%
Alzheimer's Disease
19%
Bleeding
19%
Heparin
18%
Medical Radiation Science
18%
Pre-diabetes (pre-DM)
18%
Antimalarial Drugs
18%
Importin
18%
Adenovirus
18%
Clinical Practice
18%
Pharmacist
17%
Antiphospholipid Antibodies
17%
Plasmodium Falciparum
17%
Artemisinin Derivatives
17%
Medical Radiation
17%
Enones
17%
Conjugate Addition
17%
Paramedic
17%
Preanalytical Phase
17%
Direct Oral Anticoagulants
16%
Essential Oil
16%
Cardiovascular Risk
16%
Radiation Dose
16%
Older People
16%
Inflammation
16%
Venous Thromboembolism
16%
Gene Expression
15%
D-dimer
15%
Aging
15%
Ultrasound
15%
Laboratory Diagnosis
15%
Metabolic Syndrome
15%
Type 2B Von Willebrand Disease
15%
Nuclear Import
15%
Clinical Setting
15%
New South Wales
14%
Pharmacology
14%
PFA-100
14%
Prothrombin Time
14%
Diagnostic Performance
14%
Antimalarial Activity
14%
Obesity
14%
COVID-19 Pandemic
13%
Hemostasis Laboratory
13%
Quality of Life
13%
Phenolic Extract
13%
Hematology
13%
Dihydroartemisinin
13%
PubMed
13%
Phantom
13%
Monoclonal Antibody
13%
Patient Care
13%
Zirconia
13%
Nuclear Localization Signal
13%
Medicine and Dentistry
Diagnosis
78%
Blood Stasis
72%
Diseases
64%
Von Willebrand Disease
63%
Von Willebrand Factor
55%
Systematic Review
43%
Laboratory Test
43%
Nuclear Medicine
40%
Thrombosis
37%
COVID-19
30%
Diabetes
29%
Malignant Neoplasm
28%
In Vitro
26%
Prevalence
25%
Cardiovascular Disease
24%
Meta-Analysis
24%
Computer Assisted Tomography
23%
Thrombocyte Function
23%
Diagnostic Imaging
22%
Platelet
21%
Radiographer
20%
Medicine
20%
Image Quality
20%
Randomized Controlled Trial
19%
Magnetic Resonance Imaging
19%
Drug Therapy
19%
Bleeding
18%
Oxidative Stress
18%
Infection
17%
Clinician
17%
Diabetes Mellitus
17%
Antithrombotic
17%
Breast Cancer
16%
Health Care
16%
Mammography
16%
Injury
16%
Public Health
16%
Heparin
16%
Patient Care
15%
D-Dimer
15%
Lupus Anticoagulant
15%
Awareness
15%
Impaired Glucose Tolerance
14%
Venous Thromboembolism
14%
Quality of Life
14%
Implant
14%
PFA-100
13%
Antiphospholipid Antibody
13%
Attitude
13%
Single-Photon Emission Computed Tomography
13%
Thrombophilia
13%
Dentist
13%
Hematology
13%
Prothrombin Time
13%
Direct Oral Anticoagulant
13%
Occupation (Patient Social Context)
13%
Bleeding Disorder
13%
Haemophilia A
12%
Health Care Cost
12%
Diagnostic Accuracy
12%
Blood Clotting Factor
11%
Adverse Event
11%
Radiology
11%
Antioxidant
11%
Dentistry
10%
Radiation Therapy
10%
Adipose-Derived Mesenchymal Stem Cell
10%
Scintigraphy
10%
Partial Thromboplastin Time
10%
Metabolic Syndrome
10%
Mesenchymal Stem Cell Transplantation
10%
Dental Procedure
10%
Complementary Medicine
10%
Cross Sectional Study
10%
Blood Clotting Factor 8
10%
Antiphospholipid Syndrome
9%
Clinical Trial
9%
Phlebothrombosis
9%
Diagnostic Error
9%
Cardiovascular Risk
9%
Gastrointestinal Bleeding
9%
Periodontal Disease
9%
Laboratory Assessment
9%
Arabinoxylan
9%
Immunoassay
8%
Patient Safety
8%
Thrombocyte Aggregation
8%
Blood Clotting
8%
Pathologist
8%
Polyethylene Terephthalate
8%
Biological Marker
8%
Dental Caries
8%
Prostate Cancer
8%
Monoclonal Antibody
8%
Fibrinogen
8%
Vitamin K Antagonist
8%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Placebo
8%
Polyphenol
8%
Hemostat
8%